Group items tagged

Grade 12 students from St. Elizabeth Catholic High School won first place prize in the 2009 Sanofi-Aventis BioTalent Challenge (SABC) in the Greater Toronto region. These students' research demonstrated that high frequency ultrasound could be used to test the effectiveness of a cancer therapy drug by detecting cell death in leukemia cells. MaRS is one of the Regional competition sponsors.

Grade 12 students from St. Elizabeth Catholic High School won first place prize in the 2009 Sanofi-Aventis BioTalent Challenge (SABC) in the Greater Toronto region. These students' research demonstrated that high frequency ultrasound could be used to test the effectiveness of a cancer therapy drug by detecting cell death in leukemia cells. MaRS is one of the Regional competition sponsors. April 15, 2009

Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry.

Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry. March 6, 2009

BiomedExperts is a literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide. There are maps of which scientists have worked with whom as well as a listing of their papers.

The 2010 Canada Gairdner Awards honour groundbreaking medical research behind cancer, epilepsy and heart disease and malaria treatments. Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

The US Commercial Service provides an excellent and free-for-use International Market Research search tool for 18 global industries. Global market research reports, country commercial guides, and best market reports can be accessed via search by industry, sector, region, country, keyword, or type of report. Older archived records can also be retrieved. The site offers search tips for finding market reports, as well as e-alerts.

"The United States spends more on health care-related research and development than any other country. In 2003, it was estimated that the Federal government alone spent over $26 billion. Pharmaceutical companies, device manufacturers and other private companies invested over $10 billion more. At its best, the American health care system is capable of delivering care unsurpassed anywhere else in the world. Yet, a 1999 Institute of Medicine study estimated that as many as 98,000 Americans die each year from hospital related medical errors. A recent study by the Rand Corporation (a non-profit think tank) concluded that less than 50 percent of encounters with doctors and hospitals resulted in optimal, evidence-based treatment. Studies show that as many as 42 million Americans - almost 15 percent of the population - lack health care insurance. Surveys reveal that patients do not feel they have adequate information about their conditions, and that their experience with health care ranks below that of most other sectors, in fact below that of the post office. In the aggregate, the country is spending nearly $2 trillion on health care, and yet the nation's health care system does not meet acceptable thresholds for safety, quality, access or cost. In 2005, VHA Health Foundation's board of directors sought to better understand the reasons behind this paradox. The foundation commissioned Larry Keeley and his associates at Doblin Inc. to apply the rigorous analytical methods that are used in their evaluation of other American industries and companies. The project set out to discover when, where and how innovation was taking place in health care. It also sought to identify organizations that were developing model innovation processes, and to explore where opportunities for successful innovation might lay."

Kim MacKrael, Globe and Mail reporter states, "Steven Blair, an exercise researcher at the University of South Carolina is the first winner of Canada's Bloomberg Manulife Prize for the Promotion of Active Health. " The award of $50, 000 in research was presented to Dr. Blair at the MaRS Centre.

Toronto is a globally competitive centre for groundbreaking basic and clinical research, with historical and current strengths in areas including new cancer therapeutics, stem cell research and development, genomics, bioinformatics, and the development of new diagnostic and therapeutic tools for every imaginable disease process.

MaRS connects our clients with the Consulate of Canada in San Diego through a program called MarketLink. MarketLink connects large companies to start-ups with new technology. MMB Research and Talking Plug were able to pitch their cleantech IT technology to Sony.

Two MaRS cleantech clients, MMB Research and Talking Plug present their technologies to Sony.

According the Toronto Star, Dale Richmond states that he "believes it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research."

According the Toronto Star, Dale Richmond states that he believe it is a perfect time to lobby Ottawa and Queen's Park for Toronto's needs. Successes of the past include the MaRS project that focuses on commercializing biomedical research. Jan 23, 2003

Tom Hudson is announced as the President and Scientific Director of the Ontario Institute for Cancer Research (OICR).

Tom Hudson is announced as the President and Scientific Director of the Ontario Institute for Cancer Research (OICR). Nov 13, 2006

TIFF is essential for Toronto's future but corporate support lags for its new home. Small mention of MaRS becoming a great global leader in biotech research, a great city building and creating new jobs. Sept 24, 2009

TIFF is essential for Toronto's future but corporate support lags for its new home. Small mention of MaRS becoming a great global leader in biotech research, a great city building and creating new jobs.

MaRS Innovation and The University of Toronto (U of T) announce that they have entered into an agreement to collaboratively commercialize a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers.

Scientists have been working at a rapid pace over the past year to refine a process that allows them to replicate human embryonic stem cells, without the controversial use of a human embryo. Mention of Gordon Keller, a senior stem-cell scientist working out of the MaRS centre.

Scientists have been working at a rapid pace over the past year to refine a process that allows them to replicate human embryonic stem cells, without the controversial use of a human embryo. Mention of Gordon Keller, a senior stem-cell scientist working out of the MaRS centre. Jan 2, 2009

Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre.

Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre. March 4, 2009

As stated in the NewsRX press release, studies conducted from D. Angoulvant and co-researchers found cell-based gene therapy can enhance the effects of cell transplantation by temporally and spatially regulating the release of the gene product.

As stated in the NewsRX press release, studies conducted from D. Angoulvant and co-researchers found cell-based gene therapy can enhance the effects of cell transplantation by temporally and spatially regulating the release of the gene product. March 16, 2009

Canada's lead federal funding agency for health research, this website collects funding news and developments from all over Canada, including: * Funding opportunities * How to apply for funding * Funding enquiries

Canada's lead federal funding agency for health research, this website collects funding news and developments from all over Canada, including:\n\n * Funding opportunities\n * How to apply for funding\n * Funding enquiries

whitepaper on investment sources for medical research

Karl Martin turned a pure research project into a commercial venture set to change how we interact with the emerging "surveillance society" by improving personal privacy. U of T's Innovations and Partnerships Office and the MaRS Centre came on board to help these researchers patent their work and attain funding opportunities.

The 2010 Canada Gairdner Awards honour groundbreaking medical research behind cancer, epilepsy and heart disease and malaria treatments. Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.